153 related articles for article (PubMed ID: 28116600)
1. Transungual Gel of Terbinafine Hydrochloride for the Management of Onychomycosis: Formulation, Optimization, and Evaluation.
Thatai P; Sapra B
AAPS PharmSciTech; 2017 Aug; 18(6):2316-2328. PubMed ID: 28116600
[TBL] [Abstract][Full Text] [Related]
2. Microemulsion-based gel of terbinafine for the treatment of onychomycosis: optimization of formulation using D-optimal design.
Barot BS; Parejiya PB; Patel HK; Gohel MC; Shelat PK
AAPS PharmSciTech; 2012 Mar; 13(1):184-92. PubMed ID: 22187363
[TBL] [Abstract][Full Text] [Related]
3. Design and evaluation of microemulsion-based efinaconazole formulations for targeted treatment of onychomycosis through transungual route: Ex vivo and nail clipping studies.
Agrawal V; Patel R; Patel M; Thanki K; Mishra S
Colloids Surf B Biointerfaces; 2021 May; 201():111652. PubMed ID: 33740733
[TBL] [Abstract][Full Text] [Related]
4. Design and development of a safer non-invasive transungual drug delivery system for topical treatment of onychomycosis.
Pal P; Thakur RS; Ray S; Mazumder B
Drug Dev Ind Pharm; 2015; 41(7):1095-9. PubMed ID: 24980914
[TBL] [Abstract][Full Text] [Related]
5. Terbinafine hydrochloride nail lacquer for the management of onychomycosis: formulation, characterization and in vitro evaluation.
Thatai P; Sapra B
Ther Deliv; 2018 Feb; 9(2):99-119. PubMed ID: 29325509
[TBL] [Abstract][Full Text] [Related]
6. Formulation development and optimization of transungual drug delivery system of terbinafine hydrochloride for the treatment of onychomycosis.
Patel MM; Vora ZM
Drug Deliv Transl Res; 2016 Jun; 6(3):263-75. PubMed ID: 26926242
[TBL] [Abstract][Full Text] [Related]
7. Terbinafine Hydrochloride Trans-ungual Delivery via Nanovesicular Systems: In Vitro Characterization and Ex Vivo Evaluation.
Elsherif NI; Shamma RN; Abdelbary G
AAPS PharmSciTech; 2017 Feb; 18(2):551-562. PubMed ID: 27138036
[TBL] [Abstract][Full Text] [Related]
8. Microemulsion-based antifungal gel delivery to nail for the treatment of onychomycosis: formulation, optimization, and efficacy studies.
Barot BS; Parejiya PB; Patel HK; Mehta DM; Shelat PK
Drug Deliv Transl Res; 2012 Dec; 2(6):463-76. PubMed ID: 25787325
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Ungual Permeation of Terbinafine HCl Delivered Through Liposome-Loaded Nail Lacquer Formulation Optimized by QbD Approach.
Shah VH; Jobanputra A
AAPS PharmSciTech; 2018 Jan; 19(1):213-224. PubMed ID: 28681334
[TBL] [Abstract][Full Text] [Related]
10. Formulation evaluation of ketoconazole microemulsion-loaded hydrogel with nigella oil as a penetration enhancer.
Amra K; Momin M
J Cosmet Dermatol; 2019 Dec; 18(6):1742-1750. PubMed ID: 30980617
[TBL] [Abstract][Full Text] [Related]
11. Novel nail penetration enhancer containing vesicles "nPEVs" for treatment of onychomycosis.
Bseiso EA; Nasr M; Sammour OA; Abd El Gawad NA
Drug Deliv; 2016 Oct; 23(8):2813-2819. PubMed ID: 26447337
[TBL] [Abstract][Full Text] [Related]
12. Effect of Different Nail Penetration Enhancers in Solid Lipid Nanoparticles Containing Terbinafine Hydrochloride for Treatment of Onychomycosis.
Abobakr FE; Fayez SM; Elwazzan VS; Sakran W
AAPS PharmSciTech; 2021 Jan; 22(1):33. PubMed ID: 33404930
[TBL] [Abstract][Full Text] [Related]
13. A study on the effect of inorganic salts in transungual drug delivery of terbinafine.
Nair AB; Sammeta SM; Vaka SR; Narasimha Murthy S
J Pharm Pharmacol; 2009 Apr; 61(4):431-7. PubMed ID: 19298688
[TBL] [Abstract][Full Text] [Related]
14. Oral bioavailability enhancement of raloxifene by developing microemulsion using D-optimal mixture design: optimization and in-vivo pharmacokinetic study.
Shah N; Seth A; Balaraman R; Sailor G; Javia A; Gohil D
Drug Dev Ind Pharm; 2018 Apr; 44(4):687-696. PubMed ID: 29168671
[TBL] [Abstract][Full Text] [Related]
15. Fabrication of Dissolvable Microneedle Patches Using an Innovative Laser-Cut Mould Design to Shortlist Potentially Transungual Delivery Systems: In Vitro Evaluation.
Albarahmieh E; AbuAmmouneh L; Kaddoura Z; AbuHantash F; Alkhalidi BA; Al-Halhouli A
AAPS PharmSciTech; 2019 Jun; 20(5):215. PubMed ID: 31172376
[TBL] [Abstract][Full Text] [Related]
16. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
Elsayed MM
J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
[TBL] [Abstract][Full Text] [Related]
17. Transungual Delivery of Ketoconazole Nanoemulgel for the Effective Management of Onychomycosis.
Mahtab A; Anwar M; Mallick N; Naz Z; Jain GK; Ahmad FJ
AAPS PharmSciTech; 2016 Dec; 17(6):1477-1490. PubMed ID: 26857516
[TBL] [Abstract][Full Text] [Related]
18. Terbinafine hydrochloride loaded liposome film formulation for treatment of onychomycosis: in vitro and in vivo evaluation.
Tanrıverdi ST; Hilmioğlu Polat S; Yeşim Metin D; Kandiloğlu G; Özer Ö
J Liposome Res; 2016; 26(2):163-73. PubMed ID: 26226352
[TBL] [Abstract][Full Text] [Related]
19. Co-delivery of terbinafine hydrochloride and urea with an in situ film-forming system for nail targeting treatment.
Yang F; Yu X; Shao W; Guo P; Cao S; Wang M; Wang Y; Wu C; Xu Y
Int J Pharm; 2020 Jul; 585():119497. PubMed ID: 32504773
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the antifungal efficacy of terbinafine hydrochloride and ciclopirox olamine containing formulations against the dermatophyte Trichophyton rubrum in an infected nail plate model.
Täuber A; Müller-Goymann CC
Mol Pharm; 2014 Jul; 11(7):1991-6. PubMed ID: 24490976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
